LYEL
NASDAQ · Biotechnology
Lyell Immunopharma Inc
$14.86
-0.14 (-0.93%)
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+88.1% upside
Low Target
$18.45
Average Target
$27.95
High Target
$35.39
Current Price
$14.86
Current
$14.86
$14.86
Target
$27.95
$27.95
$18.45
$27.95 avg
$35.39
Scenario Analysis
Bear Case
$18.45
24.2%
Low target
Base Case
$27.95
+88.1%
Avg target
Bull Case
$35.39
+138.2%
High target
Risk/Reward
5.7x
Highly favorable
Price in Context
52-Week High
$45.00
-67.0% from high
52-Week Low
$7.20
+106.5% from low
Target vs 52W High
$27.95
-37.9% vs high
Next Earnings Report
Nov 9, 2026
Today
EPS Est: $-2.11
Earnings in today. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -11.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +117.3% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.9% |
| MRNA | Hold | 31 | 32% | $149.45 | -41.2% |
| REGN | Buy | 36 | 72% | $76.80 | -91.5% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -54.0% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -40.7% |